2021 EANO/ESMO临床实践指南：实体瘤脑转移患者的诊断，治疗和随访

2021-08-05 欧洲神经肿瘤协会 Ann Oncol.2021 Aug 5;

2021年8月，欧洲神经肿瘤协会(EANO)联合欧洲肿瘤内科学会(ESMO)共同发布了实体瘤脑转移患者的诊断，治疗和随访指南。主要内容涵盖了预防、诊断、治疗和随访，但缺乏鉴别诊断、治疗方法的不良影响以

中文标题：

英文标题：

diagnosis

发布机构：

欧洲神经肿瘤协会

发布日期：

2021-08-05

简要介绍：

2021年8月，欧洲神经肿瘤协会(EANO)联合欧洲肿瘤内科学会(ESMO)共同发布了实体瘤脑转移患者的诊断，治疗和随访指南。主要内容涵盖了预防、诊断、治疗和随访，但缺乏鉴别诊断、治疗方法的不良影响以及姑息治疗等。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=a8fb81c00215a5f5, title=2021 EANO/ESMO临床实践指南：实体瘤脑转移患者的诊断，治疗和随访, enTitle=diagnosis, guiderFrom=Ann Oncol.2021 Aug 5;, authorId=0, author=, summary=2021年8月，欧洲神经肿瘤协会(EANO)联合欧洲肿瘤内科学会(ESMO)共同发布了实体瘤脑转移患者的诊断，治疗和随访指南。主要内容涵盖了预防、诊断、治疗和随访，但缺乏鉴别诊断、治疗方法的不良影响以, cover=https://img.medsci.cn/2021815/1629013628638_2020535.jpg, journalId=0, articlesId=null, associationId=1036, associationName=欧洲神经肿瘤协会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Aug 05 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年8月，欧洲神经肿瘤协会(EANO)联合欧洲肿瘤内科学会(ESMO)共同发布了实体瘤脑转移患者的诊断，治疗和随访指南。主要内容涵盖了预防、诊断、治疗和随访，但缺乏鉴别诊断、治疗方法的不良影响以及姑息治疗等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=10028, tagName=脑转移瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=10028, guiderKeyword=脑转移瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14444, appHits=136, showAppHits=0, pcHits=622, showPcHits=14308, likes=1, shares=25, comments=6, approvalStatus=1, publishedTime=Sun Aug 15 16:06:33 CST 2021, publishedTimeString=2021-08-05, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 15 15:47:15 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 20:38:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 EANO_ESMO临床实践指南：实体瘤脑转移患者的诊断，治疗和随访.pdf)])

2021 EANO_ESMO临床实践指南：实体瘤脑转移患者的诊断，治疗和随访.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1208093, encodeId=a5ce12080930a, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d31b5316754, createdName=1489c796m97(暂无昵称), createdTime=Sat Apr 02 11:41:35 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208094, encodeId=23da120809459, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa66246105, createdName=146572_4076, createdTime=Sat Apr 02 11:42:42 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192654, encodeId=ae011192654ec, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70ae5225349, createdName=1478bd89m27暂无昵称, createdTime=Sat Feb 12 12:31:03 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056363, encodeId=9584105636328, content=有积分不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJghY6kJrb4qteTcWjQMJmlzUFjdTITxVPA88U3EicxFQoiaVS51iaXavp0Yia84bKDdYnC6XpOYic7n9w/132, createdBy=d8ef2246210, createdName=Icefirefox, createdTime=Thu Sep 30 07:54:12 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009703, encodeId=4b8b1009e036a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/1f7bcc47e19e459f84f162cbdd4e7e4c/f96be1903e2644a39fb32c7d667dbc9c.jpg, createdBy=312c5456893, createdName=ms温馨, createdTime=Fri Aug 20 12:51:21 CST 2021, time=2021-08-20, status=1, ipAttribution=)]
2022-04-02 1489c796m97(暂无昵称)

不错

50 0
[GetPortalCommentsPageByObjectIdResponse(id=1208093, encodeId=a5ce12080930a, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d31b5316754, createdName=1489c796m97(暂无昵称), createdTime=Sat Apr 02 11:41:35 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208094, encodeId=23da120809459, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa66246105, createdName=146572_4076, createdTime=Sat Apr 02 11:42:42 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192654, encodeId=ae011192654ec, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70ae5225349, createdName=1478bd89m27暂无昵称, createdTime=Sat Feb 12 12:31:03 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056363, encodeId=9584105636328, content=有积分不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJghY6kJrb4qteTcWjQMJmlzUFjdTITxVPA88U3EicxFQoiaVS51iaXavp0Yia84bKDdYnC6XpOYic7n9w/132, createdBy=d8ef2246210, createdName=Icefirefox, createdTime=Thu Sep 30 07:54:12 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009703, encodeId=4b8b1009e036a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/1f7bcc47e19e459f84f162cbdd4e7e4c/f96be1903e2644a39fb32c7d667dbc9c.jpg, createdBy=312c5456893, createdName=ms温馨, createdTime=Fri Aug 20 12:51:21 CST 2021, time=2021-08-20, status=1, ipAttribution=)]
2022-04-02 146572_4076

学习了

42 0
[GetPortalCommentsPageByObjectIdResponse(id=1208093, encodeId=a5ce12080930a, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d31b5316754, createdName=1489c796m97(暂无昵称), createdTime=Sat Apr 02 11:41:35 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208094, encodeId=23da120809459, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa66246105, createdName=146572_4076, createdTime=Sat Apr 02 11:42:42 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192654, encodeId=ae011192654ec, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70ae5225349, createdName=1478bd89m27暂无昵称, createdTime=Sat Feb 12 12:31:03 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056363, encodeId=9584105636328, content=有积分不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJghY6kJrb4qteTcWjQMJmlzUFjdTITxVPA88U3EicxFQoiaVS51iaXavp0Yia84bKDdYnC6XpOYic7n9w/132, createdBy=d8ef2246210, createdName=Icefirefox, createdTime=Thu Sep 30 07:54:12 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009703, encodeId=4b8b1009e036a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/1f7bcc47e19e459f84f162cbdd4e7e4c/f96be1903e2644a39fb32c7d667dbc9c.jpg, createdBy=312c5456893, createdName=ms温馨, createdTime=Fri Aug 20 12:51:21 CST 2021, time=2021-08-20, status=1, ipAttribution=)]
2022-02-12 1478bd89m27暂无昵称

谢谢分享

45 0
[GetPortalCommentsPageByObjectIdResponse(id=1208093, encodeId=a5ce12080930a, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d31b5316754, createdName=1489c796m97(暂无昵称), createdTime=Sat Apr 02 11:41:35 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208094, encodeId=23da120809459, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa66246105, createdName=146572_4076, createdTime=Sat Apr 02 11:42:42 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192654, encodeId=ae011192654ec, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70ae5225349, createdName=1478bd89m27暂无昵称, createdTime=Sat Feb 12 12:31:03 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056363, encodeId=9584105636328, content=有积分不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJghY6kJrb4qteTcWjQMJmlzUFjdTITxVPA88U3EicxFQoiaVS51iaXavp0Yia84bKDdYnC6XpOYic7n9w/132, createdBy=d8ef2246210, createdName=Icefirefox, createdTime=Thu Sep 30 07:54:12 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009703, encodeId=4b8b1009e036a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/1f7bcc47e19e459f84f162cbdd4e7e4c/f96be1903e2644a39fb32c7d667dbc9c.jpg, createdBy=312c5456893, createdName=ms温馨, createdTime=Fri Aug 20 12:51:21 CST 2021, time=2021-08-20, status=1, ipAttribution=)]
2021-09-30 Icefirefox

有积分不

0 0
[GetPortalCommentsPageByObjectIdResponse(id=1208093, encodeId=a5ce12080930a, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d31b5316754, createdName=1489c796m97(暂无昵称), createdTime=Sat Apr 02 11:41:35 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208094, encodeId=23da120809459, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa66246105, createdName=146572_4076, createdTime=Sat Apr 02 11:42:42 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192654, encodeId=ae011192654ec, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70ae5225349, createdName=1478bd89m27暂无昵称, createdTime=Sat Feb 12 12:31:03 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056363, encodeId=9584105636328, content=有积分不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJghY6kJrb4qteTcWjQMJmlzUFjdTITxVPA88U3EicxFQoiaVS51iaXavp0Yia84bKDdYnC6XpOYic7n9w/132, createdBy=d8ef2246210, createdName=Icefirefox, createdTime=Thu Sep 30 07:54:12 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009703, encodeId=4b8b1009e036a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/1f7bcc47e19e459f84f162cbdd4e7e4c/f96be1903e2644a39fb32c7d667dbc9c.jpg, createdBy=312c5456893, createdName=ms温馨, createdTime=Fri Aug 20 12:51:21 CST 2021, time=2021-08-20, status=1, ipAttribution=)]
2021-08-20 ms温馨

学习

79 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

2021 EANO/ESMO临床实践指南：实体瘤脑转移患者的诊断，治疗和随访

拓展阅读

科室

工具

服务